Anne La Flamme

From Wikipedia, the free encyclopedia

Anne Camille La Flamme
Alma materUniversity of Washington
Scientific career
FieldsImmunology
Thesis

Anne Camille La Flamme is a New Zealand immunologist. She is currently a professor at the Malaghan Institute at Victoria University of Wellington in New Zealand. She has a MSc entitled 'Interleukin-2 production by transgenic Trypanosoma cruzi : molecular and biochemical characterization'[1] and a PhD entitled 'Trypanosoma cruzi-infected macrophages are defective in class II antigen presentation,'[2] both from the University of Washington.

Selected works[edit]

  • Hesse, Matthias, Manuel Modolell, Anne C. La Flamme, Marco Schito, José Manuel Fuentes, Allen W. Cheever, Edward J. Pearce, and Thomas A. Wynn. "Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism." The Journal of Immunology 167, no. 11 (2001): 6533–6544.
  • Buckner, Frederick S., C. L. Verlinde, Anne C. La Flamme, and Wesley C. Van Voorhis. "Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase." Antimicrobial Agents and Chemotherapy 40, no. 11 (1996): 2592–2597.
  • La Flamme, Anne Camille, Kate Ruddenklau, and B. Thomas Bäckström. "Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis." Infection and Immunity 71, no. 9 (2003): 4996–5004.
  • La Flamme, Anne Camille, Elisabeth A. Patton, Beverley Bauman, and Edward J. Pearce. "IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis." The Journal of Immunology 166, no. 3 (2001): 1903–1911.

References[edit]

  1. ^ La Flamme, Anne C. (1994). Interleukin-2 production by transgenic Trypanosoma cruzi : molecular and biochemical characterization. Thesis (M.S.)--University of Washington. Retrieved 23 August 2021.
  2. ^ La Flamme, Anne C. (1997). Trypanosoma cruzi-infected macrophages are defective in class II antigen presentation. Thesis (Ph. D.)--University of Washington. Retrieved 23 August 2021.

External links[edit]